HAQQ CHRISTOPHER enters ELICIO THERAPEUTICS, INC. with 31.98K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/12/2023ACC: 0001140361-23-029320
Officer· See Remarks
Since Feb 2026
31.98K
Baseline shares
100% direct
31.98K
Direct ownership
1 position
103.51K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned31.98K
Total
31.98K direct31.98K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 31.98K | Direct |
| Total | 31.98K | 31.98K direct |
Derivative Holdings2
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
3.62K
Shares owned
N/A
Exercise price
13.81
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
99.89K
Shares owned
N/A
Exercise price
3.87
Expiration
—
Exercise window
—
Total
Underlying
103.51K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 13.81 | — | — | 3.62K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 3.87 | — | — | 99.89K | N/A |
| Total | 103.51K | 0.00 | ||||